Our previous study showed that GLP-1R agonists played a neuroprotective role by decreasing NF-κB and increasing glial cell-derived neurotrophic factor (GDNF) expression in MPTP-induced PD mice (Liu et al., 2015; Lv et al., 2021; Yuan et al., 2017). Here, GLP1R is linked to Parkinson disease.